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Abstract
Background: Therapeutic vaccines can be designed to enhance existing T cell memory populations for increased
protection against re-infection. In the case of herpes simplex virus type 1, recurrent disease results from reactivation of
latent virus in sensory ganglia, which is controlled in part by a ganglia-resident HSV-specific memory CD8+ T cell
population. Thus, an important goal of a therapeutic HSV-1 vaccine would be to enhance this population.
Methods: HSV-1-infected mice were treated with TAK-779 to block CCR5- and CXCR3-mediated CD8+ T cell
migration during both acute and latent infections. Additionally, HSV-1-specific CD8+ T cells were transferred into
HSV-1 latently infected mice to mimic the effect of a therapeutic vaccine, and their migration into trigeminal
ganglia (TG) was traced during steady-state latency, or during recovery of the TG-resident memory CD8+ T cell
population following stress-, and corticosterone-induced depletion and HSV-1 reactivation from latency.
Bromodeoxy uridine (BrdU) incorporation measured cell proliferation in vivo.
Results: TAK-779 treatment during acute HSV-1 infection reduced the number of infiltrating CD8+ T cells but did
not alter the number of viral genome copies. TAK-779 treatment during HSV latency did not affect the size of the
TG-resident memory CD8+ T cell population. Transferred HSV-specific CD8+ T cells failed to access latently infected
TG during steady-state latency, or during recovery of the TG resident HSV-specific CD8+ T cell population following
exposure of latently infected mice to stress and corticosterone. Recovery of the HSV-specific CD8+ T cell population
after stress and corticosterone treatment occurred with homeostatic levels of cell division and did not require
CD4+ T cell help.
Conclusions: Our findings are consistent with the notion that the CD8+ T cells in latently infected TG are a tissue-
resident memory (Trm) population that is maintained without replenishment from the periphery, and that when
this population is disrupted, it recovers without proliferation or detectable recruitment of HSV-specific CD8+ T cells
from the blood. The compartmentalization of the HSV-specific CD8+ memory T cell population in latently infected
TG will complicate the design of therapeutic vaccines.
Background
Primary herpes simplex virus type 1 (HSV-1) infections
typically occur at mucosal surfaces, where the virus
invades sensory neurons, is transported to neuronal
nuclei in sensory ganglia and establishes a life-long
latent infection. Latent infections are characterized by a
lack of virion formation despite retention of viral DNA.
However, reactivation from latency and anterograde
axonal transport can result in pathologies ranging in
severity from asymptomatic shedding to minor blisters
and sores to blindness and potentially fatal encephalitis
[1-6]. Recurrences of herpetic disease are associated
with exposure to stressors known to compromise T cell
function such as ultra violet irradiation, stress, cancer
chemotherapeutic agents, and immunosuppressive drugs
[1,7-9]. Exposure of HSV-1 latently infected mice to
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restraint stress increases serum corticosterone levels,
diminishes the trigeminal ganglion (TG)-resident CD8+
T cell population, compromises the function of the
remaining CD8+ T cells [9-11], and induces HSV-1 reac-
tivation from latency [8].
Based on the apparent link between immunesuppres-
sion and HSV-1 recurrence, several groups have
explored the role of T cells in controlling HSV-1 latency
in mice, and they have determined that T-cells are
necessary for maintaining viral latency [8,12]. CD8+ T
cells infiltrate the sensory ganglia during the primary
infection of the cornea or skin and become closely asso-
ciated with latently infected sensory neurons [13-15]. In
the C57BL/6 mouse model, at least half of the CD8+ T
cells in HSV-1 acutely and latently infected trigeminal
ganglia (TG) are HSV-specific as demonstrated by their
specificity for a known immunodominant epitope on
HSV-1 glycoprotein B (gB498-505) [15,16]. These gB498-
505-specific CD8
+ T cells (herein referred to as gB-CD8)
express an activated phenotype and form an immunolo-
gical synapse with neurons; dispelling the notion that
latent virus is ignored by the host immune system [14].
Moreover, the ganglion-resident memory gB-CD8 T
cells can block HSV-1 reactivation from latency through
release of interferon gamma (IFN-¿) or lytic granules
[12,13,15,17]. Therefore, while incapable of clearing
HSV-1 from the body, CD8+ T cells can actively sup-
press viral reactivation.
Therefore sterilizing immunity to HSV-1 is not cur-
rently feasible, but therapeutic vaccines, which improve
the size and quality of the TG resident CD8 population,
could prevent HSV-1 reactivation from latency and
rapidly control HSV-1 replication at peripheral sites
when reactivation and shedding does occur. To this end
immunization strategies designed to augment the exist-
ing immune response have been undertaken [18] and
reviewed in [19,20]. Based on the work summarized
above, the most effective therapeutic immunizations
would increase memory CD8+ T cell populations in the
sensory ganglia, in peripheral lymphoid organs, and at
sites of viral shedding.
The chemokine receptors CCR5 and CXCR3 have a
prominent role in directing the migration of neutrophils
and natural killer (NK) cells into sites of infection
including HSV-1 infected corneas [21-23], but their role
in directing CD8+ T cells into the infected TG has not
been clarified. Mice that are deficient in either of these
receptors exhibit increased HSV-1 titers in their TG fol-
lowing corneal infection [21,22,24,25], but this likely
reflects an effect on NK cell infiltration since HSV-1
replication in the TG is largely controlled by innate
immunity prior to CD8+ T cell infiltration [26]. More-
over, the increased viral load in the TG and the known
functional abnormalities of CD8 T cells limits the utility
of CXCR3-/- and CCR5-/- mice for assessing the role of
these receptors and their ligands in regulating CD8+ T
cell infiltration into the TG [27-29]. An alternative
approach is to treat mice with TAK-779 (a non-peptide
inhibitor of both CCR5 and CXCR3) beginning after
replicating virus is cleared from the TG and before CD8
+ T cell infiltration.
Recent data suggest that the CD8+ T cell population
in HSV-1 latently infected sensory ganglia may be com-
partmentalized and not replenished from the periphery,
a feature ascribed to tissue resident memory (Trm) CD8
+ T cells [30,31]. Support for this concept comes from
two types of studies. In one study the gB-CD8 memory
population was maintained in TG, but lost from the
lymphoid and other non-lymphoid tissues of IL-15-/-
mice, suggesting that the population can be maintained
without replenishment from the periphery [32]. In a sec-
ond study, HSV-1 latently infected dorsal root ganglia
(DRG) from mice expressing different CD45 alleles were
transplanted to different sites under the kidney capsule
of non-infected mice [30,33]. Following transplant vir-
tually all CD8+ T cells in the DRG were lost and HSV-1
reactivated from latency. Interestingly, the CD8+ T cell
population in each DRG recovered with all CD8+ T cells
expressing the CD45 allele of the original DRG donor.
Recovery of the CD8+ T cell population in the trans-
planted DRG was antigen specific and required recipient
dendritic cells and CD4+ T cells, suggesting that the
remaining donor CD8+ T cells in the DRG were
expanded through HSV-1 antigen presentation by infil-
trating DC and with help from recipient CD4+ T cells.
There appeared to be little if any infiltration of CD8+ T
cells from the blood as this would have resulted in
mixed CD45 allelic expression in the two DRG.
Here, we investigated the establishment and mainte-
nance of the memory gB-CD8 population in infected
TG at their true orthotopic site. Our data demonstrate a
role for CCR5 and/or CXCR3 in the initial establish-
ment of a CD8+ T cell population in latently infected
TG, but not in maintenance of the CD8+ T cell popula-
tion during viral latency. Our studies also establish a
failure of HSV-specific CD8+ T cells to infiltrate HSV-1
latently infected TG either during steady state viral
latency or during recovery of the TG-resident CD8+ T
cell population following stress and corticosterone-
induced diminution. These findings further establish the
CD8+ T cell population in latently infected sensory
ganglia as representing compartmentalized Trm-like
cells.
Methods
Mice and Virus Infection
Female C57Bl/6 (Thy1.1-/-) mice and C57Bl/6 expressing
CD90.1 (Thy1.1+/+) were purchased from Jackson Labs
Himmelein et al. Herpesviridae 2011, 2:5
http://www.herpesviridae.org/content/2/1/5
Page 2 of 10
(Bar Harbor, Maine). Mice transgenic for the HSV gly-
coprotein B specific T-cell receptor (gB-T) were a gift
from Francis Carbone. The gB-T mice were maintained
and used as homozygote for the gB-T gene and CD45.1
via sibling mating. The gB-T was also crossed onto
Thy1.1+ background by mating gB-T mice to Thy1.1+
mice and back crossing them for four generations to
yield a Thy1.1, gB-T homozygote.
The RE strain of HSV-1 used in these studies was
generated purified and quantified as previously
described [34]. Mice were anesthetized by intraperito-
neal (i.p.) injections of 1.25 milligrams of ketamine
hydrochloride and 0.125 mg of xylazine. Topical corneal
infection was then performed on unconscious mice.
Briefly, the eyes were scarred 16 times with 30-gauge
needle in a crisscross pattern, and 3 ¿l of PBS containing
1 × 105 plaque forming units of HSV-1 RE was applied
to the eye. All experimental procedures were reviewed
and approved by the University of Pittsburgh Institu-
tional Animal Care and Use Committee and conformed
to the ARVO Statement for Use of Animals in Ophthal-
mic and Vision Research.
TAK-779 Treatment
Where indicated, mice were treated subcutaneously with
150 ¿g TAK-779, a dose previously shown to effectively
inhibit the function of CCR5 and CXCR3 in vivo [35].
Control mice received a subcutaneous injection of the
vehicle (PBS).
Isolation of Lymphocytes from Tissue
For the isolation of lymphocytes from the spleen, blood,
lungs, TG and cornea mice were anesthetized with 2.5 mg
of Ketamine and 0.25 mg xylazine. The anesthetized mice
were then euthanized by exsanguination following intra-
peritoneal injection of heparin sulfate in PBS, and blood
was collected for later analysis. The spleens were mechani-
cally worked into single cell suspension. The cornea, TG,
and lungs were dissected and digested with 42, 21, and 84
units, respectively of collagenase type I (Sigma-Aldrich, St.
Louis, MO) in 100 ¿l of 5% FBS in RPMI. The digested tis-
sue was then dispersed by pipette and passed through a 40
¿m filter (BD Labware, Bedford Maine).
Quantative Real Time PCR
Total DNA was isolated from tissue using Qiagen
DNeasy spin columns (Qiagen, Valencia, CA) and quan-
tified by spectophotometry. Viral DNA was detected
using primers specific for the HSV-1 glycoprotein H
(gH): forward primer (5’-CGACCACCAGAAAACCCT
CTTT-3’), reverse primer (5’ACGCTCTCGTCTAGATC
AAAGC-3’) and probe [5’(FAM)TCCGGACCATTTTC
(NFQ)-3’. The PCR reaction was carried out as pre-
viously described [36].
Flow Cytometry
Staining of the lymphocytes with markers specific for T-
cell associated markers was carried out using previously
described methods and reagents obtained from BD
Bioscience (BD Pharmingen, San Diego, CA) [34,36].
Briefly, VLA-4 (CD49b) and LFA-1 (CD11a) were
stained with RI-2 and 2D7 clones respectively. Both
antibodies were purchased from BD Pharmigen. In vitro
cultured T-cell activation was quantified using the anti-
CD44 clone IM7 and the anti-CD69 clone H1.2 F3,
both purchased from BD Pharmigen. The CD4+ and
CD8+ T cell populations were also identified as pre-
viously described by using the anti-CD8¿ antibody clone
53.67 and the anti-CD4 clone RM4-5 purchased from
BD Pharmigen. Granzyme B staining was performed
using the BD Bioscience intracellular staining kit and
the GB II anti granzyme B antibody conjugated to APC
(Invitrogen). The antibodies employed in these studies
included: anti-Thy1.2 (CD90.2, clone 53.21), that was
conjugated either to APC (BD Pharmingen) or PE-Cy7
(eBioscience); anti-Thy1.1 (CD90.1, clone OX-7) conju-
gated to either a FITC or a PE-Cy7 (BD Pharmingen);
CD45.1 clone A20) conjugated to FITC; and CD45.2
(clone I04) conjugated to APC. The H2-Kb tetramers
containing the immunodominant gB498-505 epitope were
produced by the NIH Tetramer facility (Atlanta, GA)
and used to quantify gB-specific CD8+ T cells (gB-CD8).
BrdU staining was carried out per manufacturer’s
instructions using the BD Pharmigen BrdU FITC Flow
Kit (BD Pharmigen, San Diego, CA).
In Vitro Activation of gB specific CD8+ T-cells
Naive gBT-I transgenic spleen cells were coated for 1 h at
37°C with 1 ¿M gB peptide. Cells were then washed twice
in HEPES-buffered Earles medium containing 2.5% (vol/
vol) FCS before being cultured at a density of 1.7 × 105
cells per ml in complete medium (mouse tonicity RPMI
1640 medium: RPMI 1640 medium containing 10% (vol/
vol) FCS, 2 U/ml IL-2 50 M -mercaptoethanol, 2 mM
L-glutamine, 100 U/ml of penicillin and 100 g/ml of strep-
tomycin). After 2 d, cells were washed and IL-2 was
replaced with recombinant human IL-15 (20 ng/ml; R&D
Systems). Complete medium containing human IL-15 was
replaced every 3-4 d, and cells were used between 10 and
14 d after initiation of the culture [37].
In Vivo CD4 Depletion, BrdU administration and Stress
Mice were depleted of CD4+ T cells by i.p. injection of
0.15 mg of anti-CD4 antibody (clone GK1.5) at times
described in the text. Stress was induced by restraining
mice in aerated plastic tubes 11.5 cm long and 3 cm
wide for 12 hrs, and was begun 2 hours after lights out
to permit access to food and water prior to restraint.
Mock stressed control mice were deprived of food and
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water for the same 12 hours, but were not restrained.
After 12 hrs food and water was returned to all mice,
but only stressed mice received corticosterone (0.4 mg/
ml, Sigma-Alrdich, St. Louis, MO) in their water. After
4 consecutive stress treatments (referred to as T0) the
mice were allowed to rest for the indicated amount of
time without manipulation. When indicated mice
received i.p. injections 1 mg/mouse of BrdU (Sigma-Alr-
dich, St. Louis, MO).
Results
Blocking the chemokine receptors CXCR3 and CCR5
reduces CD8+ T cell infiltration into ganglia during acute
HSV-1 infection
Mice received a single subcutaneous injection of TAK-
779 at 6 dpi to inhibit the activity of both CXCR3 and
CCR5 [38] during the initial CD8+ T cell infiltration of
the TG that occurs 6-8 days after HSV-1 corneal infec-
tion. Total CD8+ T cells and gB-CD8 were quantified by
flow cytometry on dispersed cells from individual TG at
8 dpi. The TAK-779 treatment significantly reduced the
CD8+ T cell population in the TG compared to mock
treated (PBS) controls, while not altering the frequency
of gB-CD8 (Figure 1A&1B). The reduced CD8+ T cell
population in TAK-779 treated mice did not affect the
HSV-1 viral burden in the TG (Figure 1C), which is
largely controlled by the innate immune system prior to
CD8+ T cell infiltration [26].
CXCR3 and CCR5 are not required to maintain the
memory CD8+ T cell population within latently infected
TG
The CD8+ effector T cells in the acutely infected TG
undergo contraction and establish a stable memory
population by 30 dpi [14]. To interrogate the role of
CXCR3 and CCR5 in maintaining the memory CD8+ T
cell population in latently infected TG, mice were trea-
ted with TAK-779 or PBS as a control at 30, 32, and 34
dpi, and total CD8+ T cells and gB-CD8 were quantified
in the TG at 36 dpi. As illustrated in Figure 2, TAK-779
treatment did not influence the size of the total CD8+ T
cell population (Figure 2A) in the TG, or the frequency
of gB-CD8 (Figure 2B). Thus, the chemokine receptors
CXCR3 and CCR5 do not appear to be required to
maintain the CD8+ T cell population within HSV-1
latently infected TG, at least for the 6 day observation
period employed.
CD8+ T cells in latently infected TG of both mice and
humans tend to cluster around latently infected neu-
rons, some forming immunological synapses with the
neurons, and most expressing an activated phenotype.
Mechanisms governing the attraction of CD8+ T cells to
infected neurons and their activation status are
unknown. Here we show that blocking CXCR3 and
Figure 1 Effect of systemic TAK-779 treatment on CD8+ T cell
infiltration into HSV-1-infected ganglia. Six days following
corneal HSV-1 infection, B6 mice were treated subcutaneously with
150 ¿g/mouse TAK-779 or with an equal volume of PBS. Two days
following treatment, TG were excised and dispersed into single cells.
The cells were stained for surface CD8¿, CD45, and gB-specific T cell
receptor, and analyzed by flow cytometry. Data represent the mean
± standard error of cumulative data for total CD8+ T cells (A) or gB-
CD8 (B) per TG from three experiments involving a total of 6 PBS-
treated and 11 TAK-779 treated mice. (C) DNA extracted from
dispersed TG cells and analyzed by real-time PCR for the number of
viral glycoprotein H (gH) gene copies revealed no significant group
differences. A two-tailed Students t test was used for all statistical
analyses.
Figure 2 Effect of TAK-779 treatment during HSV-1 latency on
size and activation of memory CD8+ T cell population. HSV-1-
infected mice were treated with TAK-779 or PBS at 30, 32 and 34
days post-infection (dpi). TG were excised 36 dpi, dispersed into
single cells, stained for CD45, CD8¿, and gB-specific T cell receptor,
total CD8+ T cells (A) or gB-CD8 (B) per TG are presented. Data
represent the means and standard errors for 9 PBS treated and 8
TAK-779 treated mice from 2 independent experiments. (C)
Alternatively dispersed TG cells were stained for activation markers,
CD69 and granzyme B (GrB). Data shown are the means and
standard errors for 4 mice per group. Students t test revealed no
statistical difference between the groups.
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CCR5 with TAK-779 for 6 days did not alter the activa-
tion phenotype of TG-resident CD8+ T cells (Figure
2C).
HSV-specific CD8+ T cells in the peripheral blood do not
migrate into HSV-infected ganglia during viral latency
It has recently been suggested that the CD8+ T cell
population within HSV-1-infected ganglia is compart-
mentalized, self-sustainable, and does not require
replenishment from the circulating lymphocyte pool
[39]. We employed adoptive transfer studies in which
CD45.2+ gB-CD8 memory or effector T cells were trans-
ferred to latently infected mice and their migration into
the TG was monitored. In a first set of experiments gB-
CD8 T cells were obtained from the spleens of CD45.2+
gBTI1.1 mice 30 days after HSV-1 corneal infection, and
transferred to latently infected CD45.1- mice. The trans-
ferred and endogenous gB-CD8 T cells were quantified
in the spleen, blood, and TG of the recipient mice 2.5
and 4.5 weeks after transfer. As illustrated in Figure 3,
the gB-CD8 T cells in the spleen and blood of recipient
mice contained an equal or greater frequency of donor
cells at all times tested, but no donor cells were detected
in the TG. Thus there is no detectable infiltration of
HSV-1 specific CD8+ T cells into the TG during stable
latency.
Repopulation of the TG following disruption via stress
and corticosterone is not dependent on proliferation
We previously established that exposure of latently
infected mice to corticosterone or restraint stress
reduces the CD8+ T cell population in the TG, and
exposure to restraint stress additionally induces HSV-1
reactivation from latency [8] (and Freeman and Hen-
dricks, unpublished data). Here we show that simulta-
neous exposure of latently infected mice to stress and
corticosterone on 4 consecutive days (30-34 dpi)
reduced the CD8+ T cell population in the TG by >80%
(Figure 4A), but both the total CD8+ T cell and the gB-
CD8 T cell populations fully recovered within 4 days. It
is interesting to note the original 1:1 ratio of gB-CD8 to
gB-non-specific CD8+ T cells was maintained following
recovery of the population. Treatment also resulted in
HSV-1 reactivation from latency as assessed by a signifi-
cant increase in HSV-1 genome copy number in the TG
and detection of HSV-1 genomes in the ipsilateral cor-
nea (Figure 4B).
Figure 3 Adoptively transferred gB-specific CD8+ T cells are
excluded from HSV-1-infected TG during stable latency. CD8+ T
cells were isolated from 30 dpi gBT I.1 (CD45.2) spleens and 106
cells were intravenously (i.v.) injected into latently infected wild-type
mice (CD45.1). At indicated times after transfer, spleens, blood, and
TG were harvested and stained for CD8¿, CD45, CD45.1, CD45.2, and
gB-specific T cell receptor. Data represent the percentage of gB-
specific cells that are CD45.1+ (endogenous). Data shown are the
means and standard errors for 3 mice at each time point.
Figure 4 Following disruption of the TG-resident CD8+ T cell
population via stress and corticosterone treatment,
repopulation occurs independent of proliferation. Latenly
infected mice received 4 days of restraint stress and corticosterone-
treated drinking water (400 ¿g/ml), followed by 1.5, 2, and 4 days of
fresh water. TGs were harvested and stained with CD8¿, CD45, and
gB-specific T cells receptor. (A) The numbers of CD8¿+ cells and
CD8¿+gB+ were quantified via flow cytometry. Data shown are the
means and standard errors for 7 (time point 0), 5 (time point 1.5),
and 12 (time point 4) mice from two independent experiments. (B)
RT-PCR of DNA from ganglia and corneas shows increased gH
copies after stress and corticosterone treatment. gH copies peak in
the TG at 4 days after stress and corticosterone while detectable
viral burden in the cornea peaks at 2 days after fresh water (Fisher’s
exact test). RT-PCR of DNA from corneas shows increased detectable
gH copies 2 days after stress and corticosterone treatment ended.
TG data represents means and standard errors from 6 mice (No
stress and day zero) or 2 mice (day two and four). (C) BrdU was
given intraperitoneally (i.p.) 12 hours after fresh water. TG were then
harvested 1.5 days after stress and stained for CD8¿, CD45, gB-
specific T cell receptor, and BrdU incorporation. Data represent
means and standard error of 9 mice from 2 experiments.
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We hypothesized that recovery of the CD8+ T cell
population in the TG after stress and corticosterone
treatment would involve proliferation of the remaining
cells, infiltration of CD8+ T cells from the blood, or a
combination of both. We favored proliferation as re-
establishing the original frequency of gB-specific CD8+
T cells through infiltration from the blood would seem
unlikely. However, the level of proliferation in the recov-
ered population as assessed by BrdU incorporation was
similar to that of the unperturbed population in mock
treated mice that were not exposed to corticosterone
and stress (Figure 4C), suggesting that recovery was not
accomplished through proliferation of remaining cells.
HSV-specific CD8+ T cells in the peripheral blood do not
migrate into HSV-infected ganglia following disruption of
the TG-resident CD8+ T cells
Therefore, we explored the alternative possibility that
recovery of the CD8+ T cell population in the TG follow-
ing corticosterone and stress treatment was accomplished
by infiltration of CD8+ T cells from the blood. Memory
and effector gB-CD8 T cells were generated in vitro by
pulsing gBT-1 Thy 1.1+ spleens with the gB peptide
(SSIEFARL) in the presence of IL-2 for three days (effec-
tor cells), followed by culture with IL-15 for 10 days
(memory cells) as previously described [37]. The effector
cells were CD44high CD69+ LFA-1low VLA-4low whereas
the memory cells were CD44 high CD69- LFA-1high VLA-
4high (Figure 5A). Latently infected Thy1.2 mice were
exposed to stress and corticosterone for 4 days followed
by adoptive transfer of effector or memory gB-CD8T
cells. The TG, blood, spleens, and lungs were obtained 4
days after transfer, and the donor (Thy1.1) and recipient
(Thy1.2) gB498-505-specific CD8
+ T cells were quantified.
As illustrated in Figure 5B&5C the donor effector and
memory cells comprised a significant portion of the gB-
CD8 T cells in the spleen, blood, and lungs of recipient
mice, but were undetectable in the TG. These findings
do not support the concept that recovery of the CD8+ T
cell population in the TG is through infiltration of HSV-
1 specific CD8+ T cells from the blood.
Repopulation of the TG following stress and
corticosterone does not depend on CD4+ T cells
A previous study demonstrated that CD4+ T cells are
required for recovery of the CD8+ T cell population in
latently infected TG following transplantation under the
kidney capsule of recipient mice [33]. To determine if
this is also true for recovery of the CD8+ T cell popula-
tion in latently infected TG at the orthotopic site, latently
infected mice were treated with stress and corticosterone
on 4 consecutive days (30-34 dpi) and received anti-CD4
mAb on the first and last day of treatment. As shown in
Figure 6A, the TG were completely depleted of CD4+ T
Figure 5 Following disruption of the TG-resident CD8+ T cell
population via stress and corticosterone treatment, in vitro
generated effector or memory cells do not enter the TG.
Spleens from naïve gBT I.1 Thy 1.1 mice were pulsed with SSIEFARL
(gB498-605) and incubated in IL-2 for three days (effector cells) and
some cells were further incubated for 10 days with IL-15 replacing
IL-2 to generate memory cells. (A) Cells were stained for CD44,
CD69, LFA-1, and VLA-4 and analysed by flow cytometry. Latently
infected wild type mice (Thy1.2+) were subjected to 4 consecutive
days of restraint stress and corticosterone. After the final treatment
mice received an adoptive transfer of 106 effector (B) or memory
(C) CD8+ T cells (Thy1.1+). Four days after the adoptive transfer,
spleens, blood, lungs, and TGs were harvested and stained for CD8¿,
CD45, Thy1.1 (Donor), Thy1.2 (Recipient), and gB-specific T cell
receptor. Data represent means and standard errors of the
percentages of gB-CD8 that are of donor (Thy1.1) or recipient
(Thy1.2) origin in the specified tissues (n = 4 mice per group). The
experiments were repeated with similar results.
Figure 6 CD4+ T cells are not required for the recovery of CD8
+ T cells within corticosterone-treated ganglia. Mice latently
infected with HSV-1 received 4 days of restraint stress and
corticosterone treatment (30-34 dpi). At 27 and 30 dpi mice
received intraperitoneal injections of 0.75 mg/ml ¿-CD4 monoclonal
antibody (clone GK1.5) or a control antibody. TG were excised at 38
dpi and stained for CD8¿, CD4, CD45, and gB-specific T cell receptor.
(A) Represenative dot plots demonstrate effective depletion of CD4
+ T cells in the TG at 34 and 38 dpi. (B) Quantification of the CD4
depletion in mock depleted and CD4-depleted groups. (C) TG were
excised at 38 dpi and analysed for recovery of the CD8+ T cell
population. Data are presented as means and standard errors of 15
(mock depleted) or 16 (CD4-depleted) mice from 3 independent
experiments. Students t test revealed no significant differences in
the number of CD8+ T cells within TG from the mock depleted or
CD4-depleted groups.
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cells at the end of treatment and 4 days later (Figure 6B)
when the CD8+ T cell population had fully recovered.
However, CD4+ T cell depletion had no effect on recov-
ery of the CD8+ T cell population in the TG (Figure 6C).
Discussion
The frequency of HSV-1 reactivation from latency in ex
vivo TG cultures is inversely proportional to the size of
the ganglionic CD8+ T cell population [40]. Based on
these findings some have advocated that all future HSV-
1 vaccines be evaluated based on their capacity to
enhance the HSV-specific CD8+ T cell population in
latently infected sensory ganglia. Such an approach
would only be feasible if the HSV-specific CD8+ T cells
expanded in peripheral lymphoid organs through immu-
nization have access to latently infected ganglia.
Evidence obtained in a model system in which latently
infected DRG are transplanted under the kidney capsule
of recipient mice suggest that HSV-specific CD8+ T
cells do not infiltrate latently infected DRG even when
the resident CD8+ T cell population is substantially dis-
rupted [33]. However, a number of factors that may be
unique to the transplanted tissue could have influenced
CD8+ T cell migration in that model. The authors sug-
gested that the loss of CD8+ T cells from the DRG fol-
lowing transplantation was likely due to death resulting
from the trauma of transplantation. Such trauma could
also induce other changes within the microenvironment
of the latently infected ganglion such as alterations in
the chemokine and cytokine milieu that could influence
CD8+ T cell infiltration. Moreover, revascularization of
the transplanted tissue could influence T cell migration.
Based on these concerns we sought a more physiologi-
cal model in which to examine the HSV-specific CD8+
T cell infiltration into latently infected TG. We
employed a model in which HSV-1 reactivation from
latency is induced by exposure to psychological stress
rather than trauma to the TG, depletion of the gang-
lion-resident CD8+ T cell population is accomplished
through exposure to corticosterone, and CD8+ T cell
migration into infected TG is examined at the orthoto-
pic site.
Our findings strongly support the notion that the
unperturbed CD8+ T cell population in latently infected
TG is maintained without detectable replenishment
from the peripheral blood. We provide two types of evi-
dence in support of this theory. We first identified che-
mokine receptors that are used to direct CD8+ T cells
into acutely infected TG and asked if blocking these
receptors during latency would result in diminution of
the CD8+ T cell population in latently infected TG. The
chemokine receptors CCR5 and CXCR3 are highly
expressed on activated T cells and are expressed in
HSV- acutely and latently infected mouse and human
TG as are the corresponding chemokines CCL5 and
CXCL10 [24,29,41-43]. However, a direct influence of
CCR5 and CXCR3 on CD8+ T cell infiltration into
acutely or latently infected TG has not been established.
Here we demonstrate that systemic treatment with
TAK-779, a chemical non-peptide inhibitor of both
CXCR3 and CCR5 [38] significantly reduced the infiltra-
tion of CD8+ effector T cells into acutely infected TG,
but did not influence the size of the CD8+ memory T
cell population within latently infected TG. These find-
ings suggested that if the CD8+ T cell population in
HSV-1 latently infected TG is maintained through infil-
tration of CD8+ T cells from the peripheral blood, the
CCR5 and CXCR3 chemokine receptors do not appear
to play an essential role in directing their migration
despite the presence of their ligands in the TG.
More direct evidence that HSV-specific CD8 T cells
do not migrate into latently infected TG came from the
observation that adoptively transferred gB-CD8 that are
retained in the blood, spleen, lymph nodes, and lungs of
recipient mice over an extended period of at least 4.5
weeks are not detectable in the TG during the same
period (Figure 3). The above findings strongly suggest
that TG containing an established CD8+ memory T cell
population and latent HSV-1 are not permissive to CD8
+ T cell infiltration. We next asked if diminution of the
resident CD8+ T cell population through elevated serum
corticosterone levels and reactivation of HSV-1 from
latency through exposure of mice to restraint stress
would change the microenvironment of the TG, render-
ing it permissive to CD8+ T cell infiltration. However,
adoptively transferred gB-CD8 T cells did not enter the
TG from the blood even when reactivation and diminu-
tion of the TG-resident CD8+ T cell population was
induced by exposure of latently infected mice to stress
and corticosterone (Figure 4).
A caveat to these findings is that the adoptively trans-
ferred CD8+ T cells obtained from gBT1.1 mice may
not accurately reflect the migratory capability of the
endogenous gB-specific CD8+ T cell memory population
in the lymphoid organs and blood of the host. This
seems unlikely given that neither effector cells generated
through in vitro stimulation for 3 days with the gB498-
505 peptide, nor memory cells obtained by incubating
the effector cells for an additional 10 days in medium
containing IL-15 were able to enter the TG. The trans-
ferred memory population expressed high levels of the
LFA-1 and VLA-4 adhesion molecules typically used by
CD8+ T cells to enter infected tissue. Moreover, CD8+
T cells that were isolated from spleens of HSV-1 latently
infected mice (30 dpi) also failed to enter the TG during
recovery of the CD8+ T cell population following stress
and corticosterone treatment (data not shown). These
findings combined with observations made with
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transplanted HSV-1 latently infected DRG, and with
vesicular stomatitis virus infected brains strongly suggest
that once a Trm CD8+ T cell population is established
in nervous tissue, further infiltration of cells from the
blood is effectively blocked [33,44].
Since infiltration of CD8+ T cells from the blood did
not seem to account for recovery of the CD8+ T cell
population in TG of stress and corticosterone treated
mice, we concluded that recovery likely resulted from
proliferation of the remaining cells. However, prolifera-
tion (based on BrdU incorporation into CD8+ T cells)
was the same or slightly lower in the recovered popula-
tion when compared to the homeostatic proliferation of
the CD8+ T cell population in control mice that were
not exposed to stress and corticosterone. While it is
possible that a burst of proliferation was missed, the low
level of gB-specific CD8+ T cell proliferation measured
from 24-36 hours after terminating stress and corticos-
terone treatment would not seem to account for the
rapid recovery of the CD8+ T cell population.
Interesting differences between our findings and those
obtained with transplanted latently infected DRG
deserve discussion. In our study, the kinetics of CD8+ T
cell recovery, the composition of CD8+ T cell population
(frequency of gB-CD8 T cells), and the size of the recov-
ered population were all independent of CD4+ T cell
help (Figure 6). This is in contrast to the transplantation
model where donor CD4+ T cells were required for
recovery of the donor CD8+ T cell population in the
DRG. Also differing in the two models is the kinetics of
recovery of the CD8+ T cell population. In our model
recovery was complete 4 days after terminating stress
and corticosterone treatment. In contrast, recovery of
the CD8+ T cell population in the transplanted DRG
was negligible until 6 days after transplant, and peaked
at 9 days after transplant. Finally the size of the recov-
ered CD8+ T cell population in our model closely
approximated that in unperturbed control TG, while the
recovered gB-specific CD8+ T cell population in the
transplanted DRG was approximately 17-fold higher
than that observed prior to excision.
We believe these differences can be explained by dif-
ferences in the two models and may be informative. The
loss of CD8+ T cells from the DRG following transplan-
tation may reflect death of the CD8+ T cells due to the
trauma of DRG excision and transplantation as sug-
gested by the authors of that report. Thus, recovery of
the population would require proliferation of the surviv-
ing cells that were at very low levels. This could explain
the delayed kinetics of recovery and the requirement for
DC and CD4+ T cell help. In contrast, corticosterone
causes T cells to emigrate from tissues [45]. In our
model, depletion of the CD8+ T cell population from
the latently infected TG may have resulted from
migration out of the TG, followed by immigration back
into the TG over the ensuing 4 days. This would explain
the lack of proliferation of the recovered cells as well as
the lack of requirement for CD4+ T cell help. It would
also explain the identical frequency of gB-specific CD8+
T cells in the recovered and pre-treatment population.
However, the failure of adoptively transferred cells to
enter the TG during recovery would suggest selective
re-entry of the original TG-resident CD8+ T cells. This
would suggest acquisition by the TG resident CD8+ T
cells of a homing receptor that permits selective re-
entry into the latently infected TG. This possibility is
under investigation.
Our findings suggest that at some point after estab-
lishment of an HSV-specific CD8+ T cell population the
infected TG becomes resistant to further T cell infiltra-
tion. We have shown that the gB-CD8 T cells exhibit a
progressively higher functional avidity (ability to detect a
low epitope density) over time in latently infected TG,
whereas their counterparts in the spleen and lungs
showed decreased functional avidity over the same per-
iod [46]. The ability to detect very low levels of MHC/
peptide complexes on latently infected neurons would
likely enhance the ability of CD8+ T cells to provide
immunesurveillance of latently infected ganglia, but be
of lesser importance in the periphery. Therefore, there
might be a selective advantage to the host to restricting
infiltration of HSV-specific CD8+ T cells into the TG.
However, restricting entrance of CD8+ T cells into the
latently infected TG will complicate the development of
therapeutic vaccines designed to bolster the TG-resident
CD8+ T cell population.
Conclusions
Our findings suggest that augmenting the number of
circulating HSV-specific CD8+ T cells is not sufficient
to bolster the HSV-specific memory T cell population
in latently infected sensory ganglia. At some point
after establishment of an HSV-specific CD8+ T cell
population the infected TG becomes resistant to
further T cell infiltration. This might be an adaptation
designed to prevent dilution of a highly functional
CD8+ T cell population that develops over time during
latency with their less functional counterparts that are
retained in lymphoid organs. However, compartmenta-
lization of the memory population in latently infected
ganglia will complicate the development of therapeutic
vaccines designed to prevent HSV-1 reactivation from
latency by increasing the size of the CD8+ memory
T cell pool.
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